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Abstract
Background and Aims: An estimated 8% of the human genome consists of integrated
virus genomes that have been left over from past retroviral infections. These human
endogenous retroviruses (HERV) have been ravaged by mutational decay, often over
millions of years, and most have been rendered inactive. However, some still contain
open reading frames and may even code for functional protein products. Upregula-
tion of these retroelements has been observed in certain disease states and in aging
mice.
Materials and Methods: PBMC and plasma samples were previously obtained from
nonagenarians (n=7, age 90) and young controls (n=7, age 26-32, median age 28).
RNA-sequencing of the samples was performed and the expression of endogenous
human genes and HERV proviruses of the families HERV-K (HML-2) and HERV-W
was quantified. This thesis work focused on the characterization and comparison of
proviral expression values between the biological sources and across age groups.
Results: Proviral expression differed greatly between PBMCs and plasma. Age-
associated significant differential expression of three HERV-K (HML-2) and one HERV-
W provirus was found in PBMCs. Furthermore, hierarchical clustering of samples in-
dicated aging-associated differences in proviral expression patterns. No age-associated
differences in proviral expression could be found in plasma samples.
Conclusion: There are age-associated differences in the expression of HERV-K (HML-
2) and HERV-W in PBMCs. Between sample differences in proviral expressions in
plasma were too great to determine differences between age groups. The differing
proviral expression between PBMC and plasma supports the hypothesis of enriched
proviral cargo of extracellular vesicles (EV). It was not possible to determine with
confidence the origin of the EVs in the plasma samples. Investigation of proviral
expression using the same approach with larger datasets of RNA-sequencing data,
potentially from external databases, could offer further insights.
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Tiivistelmä
Tutkimuksen tausta ja tavoitteet: Arvioitu 8% ihmisen genomista koostuu endogeenisistä
retroviruksista (HERV), jotka ovat menneiden retrovirusinfektioiden geneettisiä jäänteitä.
Miljoonien vuosien aikana HERV provirukset ovat rappeutuneet mutaatioiden seurauksena,
tehden suurimmasta osasta toimintakyvyttömiä, mutta jotkut sisältävät vielä avoimia
lukukehyksiä ja jopa ohjeet toiminnallisien proteiinituotteiden tuottamiseen. Näiden
retroelementtien korkeampaa ekspressiota on havaittu vanhoissa hiirissä sekä ikääntyvissä
soluissa.
Materiaalit ja menetelmät: PBMC- ja plasmanäytteitä on aiemmin kerätty iäkkäiltä
(n = 7, ikä 90) sekä nuorilta verrokeilta (n = 7, ikä 26-32, mediaani ikä 28). Näytteiden
RNA-sekvensointi suoritettiin ja ihmisen geenien sekä HERV-K (HML-2) ja HERV-W
provirusten ekspressio laskettiin. Tässä työssä keskityttiin provirusten ekspressioarvojen
luonnehdintaan ja vertailuun niin PBMC- ja plasmanäytteiden kuin ikäryhmienkin
välillä.
Tulokset: Provirusten ekspressio erosi suuresti PBMC- ja plasmanäytteiden välillä.
PBMC-ryhmässä havaittiin kolmen HERV-K (HML-2) ja yhden HERV-W proviruksen
merkitsevä differentiaalinen ekspressio ikäryhmien välillä. Lisäksi näytteiden hierarkkinen
klusterointi viittasi ikääntymiseen liittyviin eroihin provirusten ekspressioprofiileissa.
Plasmanäytteissä ei todettu ikäominaisia eroja provirusten ekspressiossa.
Johtopäätökset: HERV-K (HML-2) ja HERV-W perheiden provirusten ekspressiossa
esiintyy ikäominaisia eroja PBMC-näytteissä. PBMC- ja plasmanäytteiden välinen
differentiaali ekspressio tukee ekstrasellulaaristen vesikkelien (EV) rikastetun proviruslastin
hypoteesia. Yksilölliset erot provirusten ekspressiossa plasmanäytteissä ylittävät ikäryhmien
väliset erot. Ei ollut mahdollista luotettavasti määrittää EV:n alkuperää plasmanäytteistä.
Samojen metodien käyttö provirusten tutkimuksessa käyttäen laajempaa aineistoa,
mahdollisesti ulkoisia tietokantoja hyödyntäen, voisi tarjota lisää tietoa.
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1. Introduction
Though the Human Genome Project and the ENCODE project (Encyclopedia of DNA
Elements) that followed have gone a long way towards mapping the functional ele-
ments of the human genome, there still remain many regions and features that very
little is known about. One of those are human endogenous retroviruses (HERVs),
which comprise an estimated 8% of our genome [22]. HERVs are remnants of an-
cient retroviruses that have become a part of us through integration into the human
genome. These endogenous retroviral elements have been ravaged by millions of
years of mutational decay, rendering many of them non-functional.
In humans, HERVs have not been shown to cause disease directly [57], yet many
associations have been reported. These include neurological diseases such as multiple
sclerosis (MS) and schizophrenia, and many autoimmune diseases such as diabetes
and systemic lupus erythematosus [10]. Changes in HERV expression have also been
noticed in cancer, and they are significant enough for there to be potential for them
to act as an early biomarker of some cancers [59]. In animals, some HERVs have
been observed to affect biology in more extreme ways. An example of this is the
intracisternal type A particle sequences (IAPs), an ERV that causes genomic damage
in mice through a high transposition rate [40]. It is possible that human physiology
too is affected by ERVs in yet undiscovered ways.
We have identified two promising avenues of HERV research. One is the immun-
odeficient state of aging. HERVs seem to behave differently in disease states and as a
result of aging. ERV expression in mice has even been claimed to be "age-dependent"
[58]. The other approach to HERV study concerns extracellular vesicles (EVs). Cells
release EVs as a form of communication and potentially for other purposes. It has
been reported that HERV mRNA and products are selectively loaded to EVs as cargo
[63].
The existence of HERVs has been known since the 1960s [60], yet their nature
as repetitive elements of the genome has made their study challenging. When a
retrovirus integrates into a genome, there is a period of duplication during which
copies of that virus spread. Therefore, many seemingly individual HERVs are derived
from the same virus, causing them to share a great degree of sequence similarity.
Mapping transcripts to the exact origin can thus be difficult. It can even be argued that
the main barriers in HERV research are technical. The more accurately and effectively
HERV expression can be measured and analyzed, the better their effects on human
physiology can be determined. Newer, better hardware and software are needed to
be utilized in their study. One such technology is RNA sequencing, made possible
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and economically feasible by recent dramatic advances in sequencing technology.
In this work, we have utilized RNA sequencing to quantify and analyze the ex-
pression of human endogenous retroviruses in the contexts of extracellular vesicles
and aging. Furthering our knowledge of HERV biology in these states could help
improve our understanding of the diseases HERVs have been associated with, as well
as aging as a whole. Even if no direct causality between HERVs and diseases can
be demonstrated, proviral expression has already been shown to change in certain
disease states and therefore there is potential for novel biomarkers.
2
2. Background
This section describes human endogenous retroviruses (HERVs) as well as the re-
lated topics of extracellular vesicles (EVs) and aging. Regarding HERV biology, the
subtopics of nomenclature, life cycle, biological significance, as well as known associ-
ations with diseases will be covered. The promise of new bionformatics methods in
the study of these topics is also considered.
2.1 Endogenous retroviruses
An estimated 8% of the human genome consists of endogenous retroviral elements
[22]. These HERVs are the genetic remnants left over from past infections by retro-
viruses, most of which occurred millions of years ago. Each individual HERV locus
in the human genome is a provirus: a virus genome that has become integrated into
the DNA of a host cell. HERV proviruses are passed on vertically, from parents to
offspring, as part of the genome.
2.1.1 Nomenclature
Before moving onto HERV biology, nomenclature of HERVs should be clarified. It is
important to note that the classification of HERV integrations into families and sub-
families is incomplete, at times inconsistent, and often confusing. Not least due to
the fact that "human endogenous retrovirus" is strictly speaking a misnomer in most
cases. Very few HERVs are actually specific to humans. The vast majority of them ap-
pear to have become integrated before species divergence of humans from primates,
and many date back much further. For example, some of the oldest endogenous
retroviruses present in humans, HERV-S/L, have also been found in reptiles and fish.
Some HERV integrations are also thought to have resulted from cross-species trans-
mission. [14]
Traditional classification of endogenous retroviruses has been done based on se-
quence similarity [14]. Such similarity can indicate that proviral insertions at different
loci actually originate from the same retrovirus. Heavily mutated older integrations
are more differentiated [19], thereby being more difficult to classify using this ap-
proach. A now common approach to HERV classification is to separate and refer to
families by the one-letter code of the amino acid that is used by transfer RNA to prime
reverse transcription [57]. However, the biological effects and expression of proviruses
do not necessarily correlate within HERV families derived through such classification.
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Furthermore, no complete list of HERV families has been published [56].
Two notable HERV families are HERV-K (HML-2) and HERV-W. HERV-K (HML-
2) is the one of the youngest HERV families, initial integration having occurred an
estimated 0.2 - 2 million years ago, and is considered the most biologically active [22].
HERV-K (HML-2) is thought to be human specific, since integrations of it have only
been found in humans [14]. This study uses the Subramanian et al. annotation of
HERV-K (HML-2) [47], which includes 91 full-length proviral sequences. [47]
HERV-K (HML-2) has been found to be polymorphic in humans, meaning that
HERV-K (HML-2) integrations are not yet fixed in the population, but rather may
vary from individual to individual. Thus, there exist integrations in the population
that are not present in assembled reference genomes. Proviruses of the family can
be present as only solo LTRs in some individuals, while retaining a more complete,
full-length genomic structure in others. [30]
HERV-W is much older in comparison, having been integrated an estimated 40
million years ago. In some ways, HERV-W has come to behave more akin to a human
gene than a virus. The protein Syncytin-1 coded for by a HERV-W provirus is needed
for normal placental development. This study uses the HERV-W annotation by Grandi
et al. [17] of 213 full-length or near full-length elements. [17]
2.1.2 Life cycle
To understand what potential biological effects HERVs may have on their hosts, it
is important to know their origins. HERV proviruses are derived from exogenous
retroviruses. Similarly to RNA viruses, retroviruses store genetic material as RNA.
However, retroviruses differ in that DNA intermediates are included in their life cycle.
This difference is significant enough that they are classified separately from RNA
viruses in the Baltimore classification of viruses [6].
To become endogenized, a retrovirus has to first infect a germ line cell that is then
used in the production of offspring. That offspring must survive to reproduce and
thus proliferate the provirus via its offspring. Eventually the provirus may become
fixed in the population on the species level. Evolutionary selection pressures on both
the genomic and organismic level affect the success of the endogenization. A retro-
virus that severely reduces the chances of survival of its host will be selected out
on the organismic level. Selection pressures continue to affect proviruses long after
becoming fixed in the population. [10]
The base genomic structure of HERVs is similar to that of exogenous retroviruses,
consisting of Gag, Pro, Pol, and Env genes and surrounded on both sides by two long
terminal repeats (LTRs) [34]. Some retroviral genomes also contain code for additional
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proteins and RNA [14]. However, mutational decay usually ravages HERV proviruses
over time, eventually leaving most nonfunctional [22]. Many HERV’s are eventually
reduced to solitary LTR’s. Some proviruses survive this mutational decay by instead
becoming useful to the host, such as HERV-W and its useful protein product Syncytin-
1. Selection pressure therefore starts working for the provirus instead of against it.
2.1.3 Biological significance
At the heart of this thesis work is the open question of the extent of biological signifi-
cance that HERV proviruses hold. Despite mutational decay and epigenetic silencing
rendering most HERV proviruses inactive in most contexts, there is a great deal of
evidence that HERVs are not just genetic fossils. A compelling argument comes from
the biological potential of the flanking LTRs. The enhancer and promoter regions of
proviral LTRs are thought to be able to affect the expression of surrounding genes
[26]. This means that even solitary HERV LTRs can potentially affect biology. The
abundance of LTRs in the human genome could mean that their effects on human
genes are widespread [10].
A more direct biological effect can result from intact proviral protein products.
Some HERV-K (HML-2) proviruses are thought to contain open reading frames (ORFs)
for all viral genes and to code for functional protein products [47]. Some younger
HERVs are claimed to contain intact code for the production of virions and that such
virus particles are capable of being released from cells and entering other cells [62].
There is even evidence that the immune system may react to these virions [62]. Addi-
tionally, some proviruses have become part of normal biological functions. A striking
example of this is the protein Syncytin-1, coded for by HERV-W [17]. Syncytin-1 is a
cell-cell fusion protein, notably involved in placental development [17].
An evolutionary purpose for the integration of retroviruses may have been to offer
protection from extant exogenous retroviruses. A current example of that may be seen
in a mouse population at Lake Casitas in California, which suffers from an infectious
degenerative neurological disease, a variant of murine leukemia virus (MLV). Some of
the mice, however, are resistant against the disease. Those mice have an apathogenic
endogenous MLV that is thought to bind and block the same cell surface receptor
that the exogenous, pathogenic variant would use [15]. It is likely that such an effect
would have occurred in humans as well at some point in time, and it is conceivable
that it could even now be the case for some polymorphic HERV-K (HML-2) variant.
A review by Jonas Blomberg et al. lists other potential beneficial roles of HERVs,
such as tissue specific enhancers[51], a polyadenylation signal and site [8], structural
and nucleic acid binding proteins capable of packaging RNA, an envelope protein
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which binds to a host surface protein, a spring-loaded transmembrane protein ready
to fuse membranes and possibly cause immunosuppression. Blomberg even claims
that a late part of the HERV life cycle may be to become "physiological servants" to
their host as their negative effects are silenced, while potential beneficial roles ensure
their survival in the genome. [10]
2.1.4 Associations with diseases
One of the main motivations of HERV research is to determine what direct or indirect
pathological effects endogenous retroviruses could have. If such connections can be
discovered and understood, it may yet help in the treatment of those pathologies. As
formerly fully functional retroviruses, it would not be surprising for HERV proviruses
to have retained some pathological potential. Direct detrimental effects of endogenous
retroviruses have been documented in non-human animals. Species such as mice
and sheep exhibit very recent ERV integrations, which still behave in the manner
of the exogenous retrovirus from which they originate. An example of this is the
intracisternal type A particle sequences (IAPs), an ERV that causes genomic damage
in mice through a high transposition rate [40].
Though no human ERV has been shown to have such a direct cause in disease [57],
many associations has been established. These include neurological diseases such
as multiple sclerosis (MS) and schizophrenia, some cancers, and many autoimmune
diseases such as diabetes and systemic lupus erythematosus [10]. For example, the
aforementioned protein Syncytin-1, is also believed to be an immunogen involved
in MS [17]. Notably, there are changes in HERV expression in cancer, and they are
significant enough to possibly act as an early biomarker of some cancers [59]. High
mRNA levels of various HERV Env genes (HERK-K, HERV-R, HERV-H) have been
found in primary breast cancer patients compared to normal controls, and these levels
were found to decrease with adjuvant chemotherapy [16]. A challenge in investigating
such associations is their directionality. It is possible that HERV expression increases
as a result of immune activity, while not being itself a cause of the activity [57].
Despite these associations with diseases, retroviruses with purely negative effects
that cannot be silenced would have been unlikely to become fixed in the gene pool,
as selective pressure would have worked against their endogenization. These patho-
logical effects of proviruses are thus only likely to happen under specific conditions,
where normal mechanisms of their silencing fail, such as in some diseases or as a
result of age-related biological changes.
An additional factor to consider is the polymorphism of HERV-K (HML-2) in hu-
man populations [30]. The direct insertion of a provirus alone can cause disruption
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of gene function in the integration locus. Therefore, this variance in provirus integra-
tions is another potential source of pathology and could cause a difference between
those who have the provirus and those who do not.
2.2 Proviral cargo of extracellular vesicles
Both beneficial and pathological roles of HERVs could be connected to extracellular
vesicles (EVs). Retroviruses are thought to be closely associated with exosome for-
mation and a viral infection can even alter the contents of exosomes, subverting their
original function [4]. This link between retroviruses and extracellular vesicles could
remain in endogenized retroviruses.
There is some evidence of such a connection, in disease states where proviruses
are more freely expressed. EVs released by tumor cells have been found to contain
cargo that is highly enriched in retrotransposon elements, including HERV mRNA
[63]. This could be a method for proviruses to exert their influence when normal
mechanisms of keeping them under control are not working. Investigation of EV
cargo could therefore advance understanding of the potential biological significance
of proviruses.
Extracellular vesicles as a whole have received renewed interest in recent years
[42]. These vesicles, containing lipids, proteins, miRNA, and mRNA, are released by
cells into the extracellular space. The vesicles can be transported to cells and their
contents may even be translated into functional proteins in the case of mRNA, and
affect gene expression in the case of miRNA. The purpose of this may be cell-to-cell
communication. Much work is still needed to understand the biology of EVs. [55]
The RNA cargo of secreted exosomes largely reflect that of their parental cells
[29]. Extracellular vesicles in circulation could originate from a variety of cell types
[13]. It is thought that EVs could possibly act as biomarkers for a variety of age-
related illnesses such as cancer, and neurodegenerative, metabolic and cardiovascular
diseases [13].
2.3 Age-related changes in proviral expression
Various biological changes are associated with aging, including changes in the ex-
pression of HERV proviruses [32]. The potential of endogenous retroviruses to act
as biomarkers of aging has been researched for example by Wada et al. already in
1993 [58]. They used PCR (Polymerase Chain Reaction) to study age-related ERV ex-
pression in mice and concluded that ERV expression in mice is "age-dependent" and
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shows potential to be a biomarker of aging in humans as well [58].
If HERVs play a role in age-related decline, understanding that role could help
in combating age-related disease. Aging is associated with a general decline in im-
mune system function, referred to as immunosenescence [31]. Connected to this is
the phenomenon of inflammaging; a low-grade, chronic, and systemic inflammation
associated with aging [31]. Another notable age-related change is the so-called "senes-
cence associated secretory phenotype", where senescent cells are no longer dividing,
yet are still metabolically active and influencing surrounding tissue [55]. Furthermore,
concentration of EVs has been found to decrease with aging [13]. With all age related
changes, it can be difficult to distinguish whether they are causes or results of aging.
Some of these age-related biological changes are strong and distinct enough that
there exists the phenomenon of the epigenetic clock: through measuring of DNA
methylation the age of the subject can be determined to surprising accuracy [24].
The rate of this epigenetic aging is not constant, neither across lifespan nor among
different individuals, and can be affected by factors such as the amount of body mass
[35].
HERVs are also subject to this epigenetic change. HERV-K methylation levels have
been found to be negatively associated with age [23] and upregulation of retroele-
ments has been reported in aging and senescent cells [11]. It seems that as we age,
the control mechanisms that keep our bodies working as intended, loosen, and as a
result, these viral elements may become freed, with pathological repercussions.
2.4 The promise of bioinformatics methods
What unites all the biological phenomena described in this chapter thus far is that
only little is known about them. The repetitive and mutated genomes of proviruses
make them difficult to locate and to determine their potential biological significance.
The small size and varied types of extracellular vesicles causes their analysis to be
challenging. The undoubtedly complex interplay of these elements with aging re-
mains to be unraveled. Past methods have proven inadequate in overcoming these
challenges.
However, recent advances in genomics and bioinformatics have already enabled
great developments in our knowledge of HERV biology [21]. Bioinformatics is a
relatively new field of research in which a combination of computational, statistical
and mathematical methods are used to study biology.
Quantitative real-time PCR has been the predominant method to study HERV
expression [5], however RNA sequencing (RNA-seq) is now showing great potential
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for HERV research [46]. RNA-seq enables quantification of HERV expression on the
individual provirus level. RNA-seq methods are able to measure the transcription of
regions of interest in the genome by quantifying the amount of mRNA originating
from each specific region. The usual target is genes, yet RNA-seq can also be utilized
in other tasks such as to study the expression of viral genes [64] or to measure the
transcription of endogenous proviruses [19]. Alignment and annotation of RNA-seq
data can be done with a splice-aware alignment tool. To be splice-aware is to be able
to account for the introns that are present in the reference genome, yet missing from
the RNA reads produced by RNA-seq.
Processing of high-throughput sequencing data is context specific, meaning that
there is no single right way to go about alignment and annotation. Generally the goal
is to achieve the maximum amount of high quality reads correctly aligned against
the genome. However, what constitutes a "high quality read" is not always clearly
defined and correct alignment can be ambiguous. A compromise between sensitivity
and specificity is always required. Sensitivity, in any analysis, is the goal of max-
imizing the number of found true positives. Specificity, in contrast, is the goal of
minimizing the number of false positives. The right balance of sensitivity and speci-
ficity is determined by the context of the analysis.
Proviruses can be studied with RNA-seq similarly to genes, though there are some
difficulties. As repetitive elements, proviruses are less differentiated than human
genes. This means that mapping transcripts originating from proviruses to correct
genomic loci can be challenging [19]. Another consideration is that HERV expression
is thought less likely to lead to functional protein products than normal gene expres-
sion, as many HERVs are thought too mutationally decayed for that. Thus, HERV
transcription may not translate to HERV expression as directly as one might other-
wise expect. Yet, proviruses can indirectly affect the expression of neighboring genes,
for example through their LTRs [26], and thus their amount of transcription is still
valuable information.
Though it is very early to discuss any clinical applications, when we know so little
of HERVs, the potential for such applications can already be seen. Though it is still
unclear if HERVs can drive diseases in humans, the expression of HERVs has been
shown to change in different contexts. With a better understanding of the associations
between HERVs and disease, proviral expression could perhaps be used to diagnose
diseases that might be difficult to identify through other means. For example, change
in HERV expression patterns may be an early sign of cell transformation and thus
could be used as a biomarker for cancer [19].
If proviral expression does indeed change with age, it could also work as an aging
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biomarker. Consequently, it could be used to determine an individual’s biological
age, which is a more accurate predictor of age-related issues than is chronological
age [24]. Risk for development of age-related diseases could be identified earlier, so
that treatment can be begun sooner and have a greater effect. Accurate measures of
biological age could have many applications, some of them outside health care, such
as to verify the age of someone with no documentation of it.
Identifying disease states in which HERVs are involved in and understanding
how HERVs are involved, could alone increase understanding of those disease states.
HERV research could similarly lead to a better understanding age-related decline and
how to combat it.
There is now a need for smaller exploratory studies to investigate different ap-
proaches and to provide information on which seem most promising. Those areas
of research may then be focused on in larger, more resource-intensive studies. In
the chapter that follows, I will outline the concrete deliverables that this exploratory
thesis work could contribute to this field.
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3. Objectives
The focus of this study was to investigate proviral expression in EVs from plasma
samples, contrasting that to proviral expression in PBMC samples derived from the
same individuals. Simultaneously, the proviral expression has been compared be-
tween two distinct age groups of the study participants. Therefore, the data can be
divided into four groups based on the two biological sources of PBMCs and plasma
as well as age groups of nonagenarians and young controls, as demonstrated in table
3.1. More information on sample selection and used datasets is provided in the next
chapter.
Table 3.1: The four sample categories that are characterized and compared in this work.
PBMC nonagenarian plasma nonagenarian
PBMC young control plasma young control
The aim of this exploratory research work has been to characterize and compare
the four HERV expression profiles formed by this categorization, in order to guide
the direction of later studies. The driving research questions were along similar lines:
What are the characteristics of the PBMC and plasma RNA HERV profiles? How do
these profiles differ between each other and across nonagenarians and young controls?
These comparisons were not the sole target of this work. The question of proviral
expression itself, whether it exists and how much, is still in contention. Do our re-
sults support the hypothesis that there is proviral expression in PBMCs and plasma?
Another concern is technical. Does our RNA-seq data analysis pipeline appear to
work? Can HERVs be investigated in this way? We have also been on the lookout for
proviruses of interest that could be studied further.
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4. Materials
The study is based on data on the expression of genes and HERV proviruses quanti-
fied through RNA-seq of PBMC and plasma samples. This chapter describes all the
steps that were taken to produce those datasets, from initial sample collection to fi-
nal preprocessing and normalization of the resulting read counts. Filtering of plasma
samples and the RNA-sequencing of all samples was done by Institute for Molecular
Medicine Finland (FIMM). Quality control, alignment, expression quantification, and
normalization was done by Genevia Technologies.
4.1 Sample collection
Blood samples were drawn from young and nonagenarian participants. There were
seven young controls aged between 26 and 32, with a median age of 28. The young
controls were healthy laboratory personnel, non-smokers with no chronic illnesses
and no infections or vaccinations within the two weeks prior to blood sample collec-
tion. The case samples were provided by seven nonagenarians, participants in the
Vitality 90+ Study, who were carefully selected to be representative of the median of
both cognitional and functional fitness. The Mini Mental State Examination (MMSE)
was used to determine mental capacity of nonagenarians [1], with a median score of
23 for the full cohort and 22 for the chosen samples. Barthel scale [44] was used to
ascertain physical capability of nonagenarians, with a median score of 85 for both co-
hort and chosen samples. All participants are female, as aging-associated changes in
gene expression have been found to differ between males and females [31]. Including
samples from males could have detrimentally affected the statistical analyses.
The low number of replicates may limit the conclusions that can be drawn from
the analyses done on the data, yet the purpose of this work is to explore the potential
of the chosen approach. For such purposes the number of replicates was deemed high
enough. [43]
4.2 RNA extraction
Whole blood samples from nonagenarians and young controls were used to extract
PBMC and plasma for RNA-seq. Purification of the RNA used for RNA-seq was done
with a miRNeasy mini kit (Qiagen, CA, USA). Quality of the RNA, in terms of con-
centration and quality was validated with a NanoDrop ND-1000 spectrophotometer
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(NanoDrop Technologies, Wilmington, DE, USA).
The plasma samples were found to be of high quality still despite a long storage
time. The structure of exosomes in plasma protects the genetic materials contained
within, as high quality mRNA has been reportedly extracted from sera stored for
over a decade [39]. The presence of intact mRNA in the samples is thereby in itself
evidence that the quantified expression originates from extracellular vesicles, since
extracellular mRNA free in the blood would have been much less likely to survive the
storage.
Use of PBMCs to study proviral expression does introduce one confounding factor
that is sample cell type heterogeneity. Peripheral blood mononuclear cells include a
variety of cell types, which could exhibit differing proviral expression. Majority of the
cell population of PBMCs are lymphocytes, such as natural killer cells, T cells, and B
cells, though some of the sample mRNA can also be expected to be from monocytes.
4.3 Filtration of plasma samples
Filters of size 0.8 µm were used to remove cell debris, platelets and other larger parti-
cles from the plasma samples in order for them to portray more accurately the extra-
cellular vesicle mRNA content. Filtering was done by Institute for Molecular Medicine
Finland (FIMM). The filtering was reported to leave only smaller RNA containing
units, such as exosomes and other extracellular vesicles, viruses, and possibly some
lipoproteins. Thus the main targets of study, exosomes and other extracellular vesi-
cles, are represented to a greater degree in the RNA sequencing. Possible problems
after filtering are a lack of rRNA making QC more challenging or just a general lack
of RNA, yet this was reported by FIMM not to be the case with these samples. Both
unfiltered and filtered plasma were sequenced to verify that the filtration worked as
expected.
4.4 RNA sequencing
The RNA sequencing was done by the Institute for Molecular Medicine Finland
(FIMM). Integrity of total RNA was evaluated with Agilent Bioanalyzer RNA nano
chips (Agilent). RNA in the samples was quantitated with Qubit RNA–kit (Life Tech-
nologies). Ribodepletion of rRNA was done with 1 ug of total RNA utilizing Script-
Seq™ Complete Gold System (Epicentre) as well as for RNA-seq library preparation.
SPRI beads (Agencourt AMPure XP, Beckman Coulter) were used for purification of
RNA-seq libraries. Evaluation of the library QC was done on High Sensitivity chips by
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Agilent Bioanalyzer (Agilent). Paired-end sequencing of RNA-seq libraries was done
using Illumina HiSeq technology with a minimum of 60 million 2x100bp paired-end
reads per sample. The resulting raw RNA-seq data in the format of fastq-files was
forwarded to Genevia Technologies for further processing.
4.5 Quality control and read trimming
The quality of the sequencing output was evaluated with the tool FastQC. Not all
samples are necessarily of high quality. If there are any significant technical problems
with a sample, it should be filtered out. Even high quality samples usually contain
reads of varying quality. Low quality reads may be trimmed or filtered out.
Though the RNA sequencing data was mostly of good quality, one nonagenarian
and one young control sample were discarded as advised by Genevia. Some trimming
and filtering of the remaining samples was needed. FastQC results guided the trim-
ming of reads that was done with the tool "Trim Galore!". A quality score of 20 was
set as the general cutoff. Trimming of both ends of reads was tailored individually
for each sample based on FastQC results. After filtering and quality control the data
was ready for alignment and annotation.
4.6 Alignment and annotation
The tool TopHat v2.0.13 [52] was used for alignment of the reads against a HERV
and gene transcriptome reference, with default parameters. It should be noted that
TopHat is deprecated and STAR or other newer aligners might perform better. TopHat
requires as input RNA-seq data as FASTQ or FASTA, a reference genome and an
annotation file. Annotation of aligned reads to proviral sources is done similarly as
for genes. Genomic loci of proviruses is all the information that is needed. HERV-K
(HML-2) annotation data was obtained from Subramanian et al. [47] and HERV-W
from Grandi et al [17].
Human genome reference build 19 (hg19) was used as the reference in alignment.
The reference genome is not derived from any single individual, but is rather an amal-
gamation of data from many individuals, modeling the shared genome. As HERV-K
(HML-2) proviruses are thought to be polymorphic in the human population [30],
some may be absent from the reference genome, yet present in the genomes of study
participants.
Reads mapping to multiple regions of the genome (non-unique) were filtered out
with SAMtools. One potential issue with this approach is that quantifying only
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unique reads biases the results against newer, less diverse HERV integrations [19].
This is due to older integrations having become more differentiated and therefore
producing a greater number of unique reads [19]. This research focuses on HERV-K
(HML-2), which is the most recent integration and thus the least differentiated. This
may cause a great deal of otherwise good reads to be thrown out. However, the ex-
pression of different HERV families is not compared, which would cause non-unique
read bias to affect the results. Ultimately, accurate mapping was prioritized over this
potential issue.
Cufflinks2 v. 2.2.1 [54, 53] was used for two data processing steps. Firstly, to
ascertain raw expression estimates with Cuffquant and then to perform geometric
normalization with Cuffnorm.
4.7 Normalization
The result of alignment and annotation is read counts for each location of interest,
in this case genes and proviruses. Lengths of genes and proviruses vary, however,
meaning that a longer transcript is more likely to have a higher number of counts
originating from it. For these counts to be accurate within a sample, the counts should
be adjusted to account for the length of each transcript. Additionally, in order for these
read counts to be comparable across samples, they should be normalized together.
The tool Cuffnorm from the Cufflinks toolset [54, 53] was used for these steps.
Cuffnorm geometric normalization was utilized, which performs normalization ac-
cording to the method originally outlined by Anders and Huber [3]. FPKMs and
read counts are scaled for each sample by the median of the geometric means of read
counts across all samples. For purposes of better representative normalization, expres-
sions of HERV elements were quantified and normalized together with ENSEMBL v.
82 gene reference set.
4.8 Ethics
Written informed consent was provided by the study participants. The research
was conducted according to the principles expressed in the declaration of Helsinki.
The study protocol was approved by the ethics committee of the city of Tampere
(1592/403/1996).
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5. Methods
This chapter describes the analyzes that were done using the normalized read count
data of genes and proviruses. The materials section outlined procurement and pro-
cessing of datasets done prior to this thesis work, while this chapter focuses on the
methods used during the thesis work itself. Identified limitations of the methods of
this study will also be clarified and discussed.
5.1 Investigation of proviral expression
Analysis of differential expression of proviruses between conditions, in this case age
groups, can be done similarly as it is done for genes. The Mann-Whitney U test was
used to determine the significance of differential expression.
It is difficult to distinguish between no expression and low expression of a gene
or provirus, based on RNA-seq data. However, a cutoff of normalized read count of
16 has been used in previous work on this PBMC dataset to separate expressed from
the not expressed proviruses. Thus, only proviruses that exhibit a normalized read
count of at least 16 in the majority of both young control and nonagenarian samples
were considered expressed when determinng significant differential expression. The
use of this cutoff was continued in this work for the purposes of continuity and
comparability.
The multiple testing problem is important to account for when testing for signif-
icant differences in the expression of a large number of genes and proviruses. When
enough tests for significance are made, some of them will by chance result in signif-
icant p-values even if none are truly significant. Strictly speaking a p-value of 0.05
means that there is a 5% chance to arrive at this result if the null hypothesis is true.
Therefore, if a thousand genes are tested for significantly differential expression, and
0.05 is chosen as the cutoff of significance, one would expect 50 of those genes to be
reported as significantly differentially expressed, even if none are in reality. To control
this false discovery rate, the Benjamini-Hochberg method [9] has been utilized in all
analyses that result in p-values. In the Benjamini-Hochberg method, the number of
expected false positives (false detection rate) is used to adjust p-values to ascertain
significance even with a very large number of tests. [33]
It should be noted that statistically significant differences do not necessary trans-
late to biologically significant differences. Fold change between age groups was used
as an additional measure to predict biological significance. Fold change is the differ-
ence in amounts between two conditions. Log 2 fold change better visually represents
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upregulation and downregulation than does raw fold change. This is due to the di-
vision of log 2 fold changes into positive and negative values, with higher absolute
value indicating greater difference. Whereas, with raw fold change upregulation is
shown by positive numbers, while downregulation is limited to between 0 and 1. In
this work fold change is only ever used as a guide and never as a strict cutoff, as even
a seemingly small difference could potentially have large biological significance.
Spearman correlation was predominantly used in this work to evaluate ranked
correlation. The differences in PBMC and plasma sample contents could discount the
linear correlation of Pearson coefficient, yet Spearman only evaluates the correlation
of ranked expression of genes and proviruses. If the same genes and proviruses are
ranked highly, and the same lowly, then there is correlation. This is irrespective of
the differences in the magnitude of proviral expression, as is seen between PBMC and
plasma samples.
5.1.1 Scaling of proviral expression with chosen housekeeping genes
As the expression seen in plasma samples was generally lower than in PBMC and
varied greatly, scaling was done with housekeeping genes in order to correct for po-
tential biases. Housekeeping genes are genes involved in basic and vital functions for
cells and they are thus universally expressed. Even designated housekeeping genes
can vary in expression across tissues. Selection of correct housekeeping tasks for each
analysis is crucial as choosing wrong housekeeping genes can skew the results. [45]
A panel of commonly used housekeeping genes, consisting of GAPDH, ACTB,
GUSB, and HPRT1 was used here, due to individual housekeeping genes having very
varied expressions. The mean of the housekeeping panel was used to scale gene and
proviral expressions.
5.2 Proviral expression patterns
The total proviral expression and differences in the expression of individual proviruses
do not tell the whole story. There can also be differences in expression patterns be-
tween age groups that are visible only when studied as a whole. Such as correla-
tions between genes and proviruses in how they are expressed in different samples.
These could indicate relationships between proviruses and genes, for example related
functions or biological pathways. Principal Component Analysis (PCA) as well as
hierarchical clustering were used to study such potential patterns.
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5.2.1 Principal component analysis
The high dimensionality of sequencing data can make it difficult to interpret. There
are many genes and many samples. PCA is a data scaling method to compact high
dimensional data into fewer dimensions to aid in the interpretation of data. PCA
analysis was done in R utilizing the prcomp-function. PCA was performed separately
for both HERV-K (HML-2) and HERV-W. PCA is a quick way to see if there are dif-
ferences, yet is limited in what can be deduced from it. Hierarchical clustering was
done as another exploratory analysis to expand and contrast the PCA.
5.2.2 Hierarchical clustering
Hierarchical clustering of the samples based on normalized provirus read counts was
done to investigate if there are subgroups of samples with similarities in their expres-
sion profiles [20]. In such agglomerative hierarchical clustering, the most similar sam-
ples or clusters are joined into a new cluster at each step, with similar samples falling
into the same cluster [12]. From the resulting hierarchical structure, one can then dis-
cern notable clusters contained within. The clustering of the expression profiles was
done to ascertain whether they would cluster differently between age groups.
Many factors can affect the clustering results. Clustering is based on measures of
similarity, and thus the chosen definition of similarity will determine how the samples
cluster together. How the data was preprocessed can affect similarity measures and
thus clustering [12]. What distribution the data points follow can be important, as
certain similarity measures assume certain distributions [12].
The accuracy of clustering results will vary greatly depending on the chosen meth-
ods and it is therefore recommended to try multiple different clustering algorithms
and parameters [12]. There is no single right approach to clustering [12]. Instead,
the used methods should be chosen based on the type of data and the context of
the clustering. Although one can evaluate the uncertainty involved in clustering [48],
clustering is usually used as an early, exploratory step in analysis [12], and other
methods can be used to further investigate and verify the results.
Hierarchical clustering of the samples based on normalized read counts was done
separately for both HERV-K (HML-2) and HERV-W. Spearman correlation was used
as the distance metric, which is robust against outliers and non-Gaussian distribu-
tions, and can capture nonlinear relationships [2, 27]. Ward’s minimum variance was
used as the linkage method, which has been reported to perform better with gene ex-
pression data than the more traditional methods of average and complete linkage [2].
Multistep-multiscale bootstrap resampling was done using the R package Pvclust to
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evaluate the uncertainty involved in the clustering [48]. Thousands of samples of vary-
ing sizes are randomly created from the data and then clustered. An approximately
unbiased (AU) p-value is obtained, which indicates the bias corrected percentage of
dendrogram variants where the specific cluster was observed.
Clustering of PBMC samples was done with all the proviruses that had a normal-
ized read count of the established cutoff of at least 16 in at least one sample. With
plasma samples all proviruses that had at least some expression (normalized read
count > 0) were used in clustering.
5.3 Inferring potential biological effects of proviruses
The aim of HERV research is not only to examine and characterize proviral expres-
sion. The goal is to determine to what extent proviruses can affect physiology and
in what ways. Gene ontology enrichment analysis was used to investigate potential
biological significance of HERV proviruses. In the case of genes, one method to in-
fer possible functions is to explore the known functions of other genes with similar
expression patterns [28]. These known functions can be retrieved from the Gene On-
tology (GO) database. The GO project is an ongoing effort to collect information on
the biological processes, molecular functions and cellular components that genes are
involved in. In the context of GO, biological process specifically refers to a "biologi-
cal objective to which the gene or gene product contributes" that is achieved through
"ordered assemblies of molecular functions" [50]. The GO database is not limited
to a listing of processes, instead containing a hierarchical structure of relationships
between processes. [50, 49]
Knowledge of HERV proviruses is far too limited for there to be a comparable
database of provirus ontology. Yet proviruses act analogous to genes in many respects
and the same approach can be extended to investigating the biological processes they
might affect. Proviral co-expression with genes that have known functions could
indicate involvement in similar biological functions.
GSEA (Gene Set Enrichment Analysis) was used in this work to infer links between
proviruses and GO terms. GSEA can be done based on a list of ranked genes. Here
the genes were ranked according to correlation in expression to a provirus, to infer
what functions the provirus in question could be involved in. A similar approach has
been adopted for example by Zhang et al., when studying co-expression of Epstein-
Barr virus genes with human genes to identify potentially affected human biological
pathways [64].
One difficulty with this approach is that unlike genes, most proviruses are not
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necessarily expected to have any function. Yet when comparing many proviruses
with many genes, there will be incidental correlations in expression. This can lead to
inflated p-values and a large number of false positives compared to few true positives.
5.4 Investigation of genomic neighborhood
In addition to searching through literature for more information on proviruses of
interest, different extended methods were also utilized for more in-depth study. Inte-
grative Genomics Viewer [41] was used to study the genomic landscape surrounding
such proviruses. The location of a provirus is of interest, because it could be located
next to, or even within, a gene. If the gene is highly expressed, this could explain a
high expression of that provirus. Furthermore, a provirus could affect the expression
of any nearby genes. Online databases and tools, such as GTEx (Genotype-Tissue
Expression) [18], were then used to follow up on locational information to investigate
if anything of interest can be found.
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6. Results and discussion
After determining that there indeed is proviral expression in both PBMC and plasma
samples, a variety of analyses were performed to characterize and compare this ex-
pression between the biological sources of PBMCs and plasma, as well as between the
age groups of young controls and nonagenarians. In this chapter, the results of the
thesis work are presented and discussed analysis by analysis.
Before proceeding with more specific analyzes the overall format of the data was
investigated. Final format of the given materials is as matrices of normalized read
counts. There is one dataset for PBMC samples and another for plasma samples. Both
contain data from the young controls and the nonagenarians. Rows of the matrices
are genes and proviruses, while columns are for different samples.
Of note is that only an extremely small portion of total quantified mRNA origi-
nates from proviruses. An overwhelming majority of it is derived from human genes,
as shown in table 6.1. Proviral expression constitutes a slightly larger portion of
all expression in PBMC than in plasma, though the difference is negligible. There
was significant differential expression of many human genes between age groups
in PBMC data, as determined by Benjamini-Hochberg corrected p-values lower than
0.05. The focus of this work is proviruses, yet this data could also be used to study
age-associated differences in gene expression. There was less differential expression
between age groups in plasma, where there were only 19 genes and no proviruses
differentially expressed.
Table 6.1: Percentage of expression from total quantified expression.
Genomic entity PBMC Plasma
Human genes 99.968 % 99.980 %
HERV-K (HML-2) proviruses 0.011 % 0.007 %
HERV-W proviruses 0.021 % 0.014 %
6.1 Proviral expression in blood cells compared to plasma
Both the overall scale of expression, as well as what proviruses are expressed, were
found to be very different between samples derived from PBMCs and from plasma.
Figure 6.1 illustrates how PBMCs had much higher overall normalized read counts
than plasma. The total normalized read count additionally greatly varied from sample
to sample in plasma samples, yet not in PBMC samples, as shown in figure 6.2. These
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differences were taken into account in following analyses by focusing on the relative
expression of proviruses, instead of the absolute read count.
(a) PBMC sample read counts by provirus. (b) Plasma sample read counts by provirus.
Figure 6.1: The problem of scale. Bar plots illustrating how normalized HERV-K (HML-2) read counts
from PBMCs and from plasma show strikingly different overall expression levels. Shown are combined
read counts per provirus from both young and nonagenarian samples, sorted in order of highest
expression separately for PBMC and plasma.
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(a) PBMC sample read counts by sample. (b) Plasma sample read counts by sample.
Figure 6.2: Bar plots showing the difference in total number of HERV-K (HML-2) normalized reads
between PBMC and plasma per sample. Samples from young controls are denoted by the letter Y, and
nonagenarians by the letter N.
Scaling of expression values based on a panel of housekeeping genes was tried, yet
the results appeared arbitrary and unreliable. Instead, methods that do not rely on
comparable absolute expression were used in this work, such as Spearman correlation
coefficient.
The expression of individual genes and proviruses was compared between PBMC
and plasma samples and it was found that the expression of genes correlated more
strongly than did proviral expression. Spearman correlation coefficient for genes be-
tween PBMC and plasma was 0.64, indicating moderate to strong correlation. For
HERV-W proviruses, the coefficient was 0.23 indicating weak to no correlation. For
HERV-K (HML-2) proviruses the coefficient was -0.0025, indicating virtually no cor-
relation.
Sample to sample correlation between PBMC and plasma expressions is illustrated
in figure 6.3. Nonagenarian participant N6 had higher correlation in gene expression
between PBMC and plasma than the others. Nonagenarian participants N4 and N5
had higher correlation in HERV-W proviral expression between PBMC and plasma.
Whereas HERV-K (HML-2) expression was very uniformly of low correlation between
PBMC and plasma.
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(a) Human gene expression
(b) HERV-K (HML-2) proviral expression (c) HERV-W proviral expression
Figure 6.3: Heatmaps of sample to sample correlation of expression values between PBMC and plasma
using Spearman correlation coefficient. Produced using R package pheatmap.
Fold changes between PBMC and plasma for each provirus were also calculated
and are shown in tables 6.2 and 6.3. Direct comparison of within experiment normal-
ized read counts between experiments is problematic, and thus these fold changes are
only shown to convey overall, relative differences between PBMC and plasma sam-
ples, and not as a absolute measurement of difference in expression for each provirus
in the two conditions.
The plasma samples have been filtered to consist mostly of extracellular vesicle
contents, and enrichment of proviral cargo in EVs has been reported, though in cancer
[63]. Therefore, this discrepancy in PBMC and plasma expression between proviruses
does support the hypothesis of proviral contents being selected for EV cargo. Of
note is that HERV-K (HML-2) shows greater difference between biological sources.
Following analyses will show that HERV-K (HML-2) was also found to be expressed
differently between age groups. If selective loading of proviruses for EV cargo does
occur, it might not be universal, but rather focused on certain families, subfamilies or
individual proviruses. It is nevertheless important to remember that the expression
of HERVs could be different for many reasons, and that these results alone cannot
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Table 6.2: HERV-K (HML-2) median expression in young controls, as measured by normalized read
count, in PBMC and plasma as well as the fold changes calculated from them. The table is ordered first
by fold change and then by median expression in PBMC. No fold change was calculated for proviruses,
which had zero expression in either PBMC or plasma.
HERV-K locus Median expression in
PBMC
Median expression in
plasma
Fold change
19q13.12a 18.10 133.54 7.38
19q11 4.91 9.42 1.92
10q24.2 8.95 6.28 -1.42
20q11.22 8.57 4.32 -1.99
9q34.3 3.81 1.40 -2.72
3q21.2 19.72 1.40 -14.07
8p23.1c 22.86 1.26 -18.18
11q12.3 8.93 0.45 -19.90
4p16.3a 16.20 0.45 -36.08
1q22 261.01 5.66 -46.13
19q13.12b 146.49 2.80 -52.25
9q34.11 36.90 0.29 -128.19
3q12.3 916.86 1.40 -654.09
12q24.33 97.25 0.00
1q23.3 78.79 0.00
7q34 74.16 0.00
1q32.2 42.30 0.00
14q11.2 27.67 0.00
4p16.1a 26.10 0.00
1q21.3 18.72 0.00
10p14 18.00 0.00
8p23.1b 17.09 0.00
11q12.1 14.65 0.00
11p15.4 12.35 0.00
3q13.2 11.47 0.00
8p23.1a 11.39 0.00
19q13.41 9.71 0.00
4p16.1b 9.44 0.00
1p31.1a 6.30 0.00
12q24.11 4.88 0.00
22q11.21 4.76 0.00
16p13.3 4.41 0.00
12p11.1 0.00 0.47
25
Table 6.3: HERV-W median expression in young controls, as measured by normalized read count, in
PBMC and plasma as well as the fold changes calculated from them. The table is ordered first by fold
change and then by median expression in PBMC. No fold change was calculated for proviruses, which
had zero expression in either PBMC or plasma.
HERV-W locus Median expression in
PBMC
Median expression in
plasma
Fold change
18p11.31 9.63 9.81 1.02
12q24.31 37.27 18.22 -2.05
11q14.2 4.69 1.40 -3.34
10q24.1 25.16 6.16 -4.08
4q21.22 15.45 3.45 -4.47
3q13.31 182.88 38.98 -4.69
3q26.32 12.71 1.89 -6.74
1p22.2a 26.36 2.06 -12.78
2q11.2 27.27 2.05 -13.27
3q13.32 58.60 3.59 -16.31
6p22.3 30.80 1.47 -20.99
1q22 11.82 0.46 -25.70
2q31.2a 31.76 0.92 -34.54
6q27b 36.58 1.03 -35.61
2q32.3 13.64 0.29 -47.37
3q23b 73.15 1.24 -59.09
1p34.2 48.72 0.47 -103.33
2p16.2 89.99 0.46 -195.73
2q22.2 113.64 0.00
6q21a 111.17 0.00
6q21c 38.13 0.00
11q14.1 36.36 0.00
Xp11.21 34.60 0.00
1q42.13 33.35 0.00
14q21.2 31.63 0.00
17q22 25.42 0.00
7q21.2 17.77 0.00
19q13.2a 17.05 0.00
9p13.3 16.31 0.00
2p23.1a 16.17 0.00
2q24.3 14.38 0.00
13q13.3 13.64 0.00
1q32.1 11.82 0.00
4p16.3 11.72 0.00
1p12 10.59 0.00
6q24.2a 10.00 0.00
17q12a 10.00 0.00
8q21.11 9.18 0.00
17q12b 9.09 0.00
15q21.3 8.89 0.00
14q32.11 7.06 0.00
3q11.2 6.67 0.00
5q22.2 4.49 0.00
7q31.1a 1.93 0.00
7p14.2 0.48 0.00
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determine the cause.
6.2 Differences in expression between age groups
There was an unexpectedly small difference in the total expression amount between
age groups in both PBMC and plasma. An expected general upregulation of proviruses
in samples derived from elderly participants was not observed. Distribution of read
origin separated by age group is shown in table 6.4.
Table 6.4: Percentage of expression for each category of genomic entity from total quantified expres-
sion, separately for both age groups.
Genomic entity
PBMC Plasma
Young Old Young Old
Human genes 99.968 % 99.968 % 99.983 % 99.977 %
HERV-K (HML-2) proviruses 0.012 % 0.011 % 0.005 % 0.008 %
HERV-W proviruses 0.020 % 0.021 % 0.012 % 0.015 %
Some proviruses were significantly differentially expressed across age groups in
PBMC samples, but none in plasma samples, as determined by Benjamini-Hochberg
corrected p-values lesser than 0.05. Many proviruses had high median fold changes
between age groups. Most HERV-K (HML-2) proviruses that were differentially ex-
pressed between age groups showed higher expression in the elderly participants.
In comparison, differentially expressed HERV-W proviruses unexpectedly showed
downregulation in the elderly.
Volcano plots that plot significance against fold change are shown in figure 6.4.
Some of the proviruses on the plot that showed promise with unadjusted p-values
were discounted by Benjamini-Hochberg p-value correction or by having a low overall
normalized read count (previously established cutoff of at least 16 in majority of both
young control and nonagenarian samples).
After filtering out proviruses with low expression and performing Benjamini-
Hochberg p-value adjustment for multiple testing, four proviruses were found to be
significantly differentially expressed in PBMC samples (p-value < 0.05), displayed in
figure 6.5. Three of those were HERV-K (HML-2) proviruses 1q22, 10p14 and 12q24.33
and one HERV-W provirus Xp11.21. Provirus 1q22 is known by aliases K102, K(C1b),
K50a, and ERVK-7 [47]. Provirus 10p14 is also known as K(C11a), K33, and ERVK-16
[47]. No aliases were found for provirus 12q24.33 or Xp11.21, besides the genomic
loci used to distinguish them in this work.
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(a) HERV-K (HML-2) proviruses
(b) HERV-W proviruses
Figure 6.4: Volcano plots showing significance plotted against fold change, when comparing age
groups based on PBMC samples. The p-values shown here have been converted to -log 10, and fold
changes are as log 2. Thus higher y-axis position indicates higher significance, while greater distance
from 0 on the x-axis indicates greater change in expression values between conditions. A positive fold
change here signifies upregulation in nonagenarians, while a negative value signifies downregulation.
Dots colored yellow indicate proviruses with high fold change (absolute log 2 fold change higher than
2), orange indicate high significance (unadjusted p-value lower than 0.05), while red dots indicate both
high significance and fold change.
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Figure 6.5: Significantly differentially expressed proviruses between young controls and nonagenari-
ans. Proviruses 1q22, 10p14 and 12q24.33 belong to the HERV-K (HML-2) family, while Xp11.21 belongs
to the HERV-W family.
Differences in proviral expression between age groups were lesser than antici-
pated, especially with plasma samples. It is possible that the low number of repli-
cates is the cause and that with a higher number of samples the age group differences
would be more prominent and less overshadowed by individual differences.
6.2.1 Patterns of expression across proviruses
Results from the Principal Component Analysis suggest that only HERV-K (HML-2)
in PBMC samples exhibits age-associated expression patterns. Plot of the first two
principal components from PCA analysis of HERV-K (HML-2) expression in PBMC
samples showed two clusters, shown in figure 6.6. PCA of HERV-W expression in
PBMC and of both provirus families in plasma samples showed no clustering at all.
Hierarchical clustering of PBMC samples produced results that mostly align with
PCA. Clustering indicated clear differences in the expression profiles between nona-
genarian and control samples with HERV-K and to a lesser extent with HERV-W, as
displayed in figure 6.7. Clustering of samples based on HERV-K (HML-2) expression
resulted in two groups separated along the age group lines. The clusters have ap-
proximately unbiased (AU) p-values of 98 and 97, which are equivalent to p-values of
0.03 and 0.02 respectively, indicating statistical significance (< 0.05). An AU p-value is
the bias corrected percentage of resampling dendrogram variants where the specific
cluster was observed. Hierarchical clustering of HERV-W did divide the samples into
the two age groups, though the estimated significance of those clusters was lesser
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(a) PBMC HERV-K (HML-2) (b) PBMC HERV-W
(c) Plasma HERV-K (HML-2) (d) Plasma HERV-W
Figure 6.6: Principal component analysis of HERV-K (HML-2) and HERV-W proviral expressions in
PBMCs and in plasma. The proportion of variance for each plot that the two principal components
account for are shown on the axis labels.
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than with HERV-K (HML-2). Clustering of HERV-W is in contrast with PCA results
where no discernible clusters were formed.
Clustering of plasma samples did not result in age-associated clusters for either
provirus family. It is possible that individual differences in expression in plasma
overshadow age group ones. It has been reported that EV concentration and content
varies from person to person, strongly enough to have personal EV profiles [13]. This
may interfere with the results. A greater number of samples could offer evidence that
is more robust. Another possibility, though rather unfeasible, could be longitudinal
studies. The issue of personal EV profiles could be avoided by comparing EV samples
from the same individuals separated by date of sample collection.
These clustering results can be seen to indicate that there truly are age-associated
expression profiles for HERVs. That the differences seen between age groups are not
just background noise in the data, but rather similarities in proviral expression within
those age groups.
Overall, the results on age group comparisons are not as clear-cut as was expected.
No universal upregulation of proviral elements was observed, though clustering re-
sults do indicate differing expression patterns between young controls and nonage-
narians. It seems that the associations between proviruses and aging are more intricate
and may be restricted to certain provirus families, subfamilies or even just individual
proviruses.
The question of the underlying mechanism then arises. What could cause these ob-
served differences in proviral expression patterns? One potential explanation is age-
related changes in epigenetic silencing. Retrotransposons in general, which HERVs
are part of, have for a long time been hypothesized to be kept under control with
epigenetic silencing, mainly through methylation [61]. ERVs have been reported to
become progressively demethylated and de-silenced in aging mice [37, 7]. This same
process could take place in humans, explaining the differential expression between
the age groups.
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(a) PBMC HERV-K (HML-2) (b) PBMC HERV-W
(c) Plasma HERV-K (HML-2) (d) Plasma HERV-W
Figure 6.7: Hierarchical clustering of PBMC samples based on normalized HERV-K and HERV-W
read counts, using Spearman correlation distance metric and Ward’s minimum variance agglomeration
method. The height separating clusters indicates proportional dissimilarity between clusters. The red
squares indicate clusters that were deemed statistically significant through bootstrap resampling (p-
value < 0.05). AU p-value indicates the bias corrected percentage of dendrogram variants where the
cluster was present. Samples from young controls are denoted by the letter Y, and nonagenarians by
the letter N.
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6.3 Origin of the extracellular vesicles
It was concluded that no definitive conclusions can be made about the origin of the
EVs based on only this data, though it can be hypothesized on. The cargo of extra-
cellular vesicles is characteristic of both the type of EV in question as well as the cell
of origin [39]. Thus, it was thought that it might be possible to state whether the
exosomes are being released from PBMCs or not based on similar expression profiles.
However, one cannot state this purely based on correlations from this sequencing
data, as there are some confounding factors. The heterogeneity of the cell types con-
tained in PBMCs is one such factor, as are the types and origins of EVs that can be
present in the plasma samples. EVs are thought to be released into circulation by a
variety of cell types. These include, but are not limited to, platelets, erythrocytes, neu-
rons, adipocytes, and endothelial cells [13]. Therefore it is very difficult to conclude
where exactly the EVs in our samples are from, or if there even is a single distinct
source or instead a mixture of sources. Even without these challenges, similarity of
expression profiles alone would arguably not be conclusive evidence. As such, the
EVs from the plasma samples cannot be stated with confidence to have been secreted
from the PBMCs.
One hypothesis on EV origin was revealed by the provirus 19q13.12a. HERV-K
(HML-2) provirus 19q13.12a was found to have very high expression in plasma, yet
unremarkable expression in PBMCs. The exact location of 19q13.12a is on chromo-
some 19, at 36063207–36067434, on the minus strand. This provirus has no known
aliases. It is instead only referred to by the inhabited locus. 19q13.12a has not been
found to contain an open reading frame, thus would not be translated and subse-
quently is less likely to have biological effects through actual products [25], yet could
have biological effects through other means.
Integrative Genomics Viewer [41] was used to investigate the genomic surround-
ings of 19q13.12a. A view of the IGV interface is shown in figure 6.8 focused on
19q13.12a. No genes or other genomic entities overlap with 19q13.12a in our data.
The nearest neighbor of the provirus is the gene ATP4A, located upstream. The
database GTEx (Genotype-Tissue Expression) [18] was queried on the gene, which
revealed that curiously ATP4A has been reported to only be expressed in gastric pari-
etal cells, located in the stomach (figure 6.9). ATP4A enzyme is needed for gastric
acid secretion, and additionally acts as a proton pump, catalyzing the hydrolysis of
ATP [36]. If ATP4A is only expressed in gastric parietal cells, then that genomic loca-
tion should be silenced in other cell types. The high expression of 19q13.12a would
indicate that the region cannot be silenced in the plasma sample derived mRNA that
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has been analyzed in this work. The mRNA could be delivered from those parietal
cells through extracellular vesicles in the bloodstream. However, it is unclear why
extracellular vesicles from those cells would be found in the blood stream in the first
place.
Figure 6.8: Integrative Genomics Viewer showing the genomic location of 19q13.12a and a nearby gene
ATP4A.
Figure 6.9: View from GTEx database on the tissues in which the gene ATP4A has been reported to be
expressed.
6.4 Inferred biological effects
The provirus 19q13.12a had very high expression in plasma, while only having low
expression in PBMCs. Due to this rather extreme difference in expression amounts,
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GSEA (Gene-Set Enrichment Analysis) was done to identify potential biological effects
of 19q13.12a through known functions of genes that have correlating expression with
the provirus. Results are displayed in table 6.5. The most significantly enriched
GO (Gene Ontology) terms appear very general, and no definitive function for the
provirus could be established from them.
Table 6.5: Top 20 results from GSEA of genes correlating with the expression of the provirus 19q13.12a.
ID p-value enrichment score description
1 GO:0034655 0.0013 0.29 nucleobase-containing compound catabolic process
2 GO:0022613 0.0013 0.44 ribonucleoprotein complex biogenesis
3 GO:0006397 0.0013 0.27 mRNA processing
4 GO:0008380 0.0014 0.30 RNA splicing
5 GO:0034470 0.0014 0.48 ncRNA processing
6 GO:0006401 0.0014 0.33 RNA catabolic process
7 GO:0006402 0.0014 0.35 mRNA catabolic process
8 GO:0000375 0.0014 0.29 RNA splicing, via transesterification reactions
9 GO:0042254 0.0014 0.53 ribosome biogenesis
10 GO:0000377 0.0014 0.30 RNA splicing, via transesterification reactions
11 GO:0000398 0.0014 0.30 mRNA splicing, via spliceosome
12 GO:0090150 0.0014 0.33 establishment of protein localization to membrane
13 GO:0016072 0.0014 0.53 rRNA metabolic process
14 GO:0006364 0.0015 0.55 rRNA processing
15 GO:0071826 0.0015 0.33 ribonucleoprotein complex subunit organization
16 GO:0006403 0.0015 0.29 RNA localization
17 GO:0006399 0.0015 0.35 tRNA metabolic process
18 GO:0000956 0.0015 0.49 nuclear-transcribed mRNA catabolic process
19 GO:0022618 0.0015 0.34 ribonucleoprotein complex assembly
20 GO:0006413 0.0015 0.51 translational initiation
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7. Conclusion
The results of this study indicate that some HERV proviruses do have measurable
expression in both PBMCs and in EVs, that there are differences in the expression of
proviruses between the young and the old, and the measured differences in provi-
ral expression between PBMCs and EVs does support the hypothesis of selectively
loaded proviral mRNA cargo of EVs. Age-associated differences were found in the
expression of some individual proviruses as well as in proviral expression patterns
across samples. These changes in expression could be due to age-related changes in
epigenetic silencing. It was not possible to determine with confidence the origin of
the studied EVs, nor the biological significance of the abnormally expressed provirus
19q13.12a.
To the best of our knowledge, such a study of proviral expression comparing age
groups and using RNA-seq has not been done before. PCR has mainly been used in
the past to compare proviral expression [5], yet it is limited in precision and scope,
and cannot be used to study the expression of all individual provirus loci across the
transcriptome. Use of RNA-seq in this manner shows promise, especially if used with
a larger number of samples.
Main limitations of the study approach were identified, such as the small sample
size, the heterogeneity of cells contained in PBMC samples, and the potential vari-
ation, in terms of type and origin, of the studied EVs. It then becomes difficult to
evaluate correlations between contexts, as the cause could be differences in cell pro-
portions, among others. The sample size was enough for an exploratory study such
as this, investigating potential avenues of research, yet a greater dataset is needed to
support any definitive conclusions.
Perhaps the most important results of this work are not about HERV biology,
but rather about how HERVs should be studied in following work. This project has
clarified the workflow that we will employ and tools that we should use in the study
of HERVs. How these conclusions will guide future studies will be discussed in the
next chapter.
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8. Future perspectives
The mentioned limitations of this study could be avoided in future studies. The rel-
atively small sample size can in some contexts be avoided by using raw sequencing
data from external databases. Gene expression has already been extensively studied
with RNA-seq, and it is becoming common practice to release the used raw sequenc-
ing data for reproducibility. Data that can be used to study gene expression can
likewise be used to study proviral expression. Thus, there are many high-quality
datasets available that have been thoroughly investigated in terms of gene expression,
yet not in proviral expression. From external databases it could also be possible to
find single-cell sequencing data, to avoid the aforementioned problem of multiple
cell types contained in PBMCs. Exosome isolated data could possibly also be found
that would similarly narrow down the types of EVs in the data. Longer read counts
could allow for greater certainty in mapping of proviral transcripts to their originat-
ing loci. Studies using additional data might not yield any new insights, but could
offer conclusions that are more concrete.
However, there are limitations to using online databases. Concerning the research
topic of the biology of aging, there are only few datasets available. Data on nona-
genarians is especially rare. High quality sequencing data isolated from EVs may
similarly be hard to obtain, though the study of exosomes has been quickly rising
in popularity. Therefore, it may be that only some of our research interests can be
satisfied with online databases. We are planning to face these difficulties by both
expanding our own datasets with data that would otherwise be hard to find, while
using external datasets when possible.
We have in this work only investigated the proviruses of HERV-K (HML-2) and
HERV-W families. While these two families are some of the most active and therefore
of potential biological significance, there are many other families that would be of
interest to study. For this task there is for example the online resource HERVd, which
is a database on proviruses [38]. It contains information on the location and intactness
of 519 060 endogenous retroviral entities. As in the quantification of gene expression,
the only thing needed to study the expression of proviruses are their genomic loci.
We are additionally planning to use more up-to-date data analysis pipelines in fur-
ther studies. Newer, possibly more effective tools such as STAR, Kallisto and DESeq2
could be used instead of Tophat and Cufflinks.
For now, the study of HERVs is the study of correlations. As stated in a review
of HERVs and disease [10], more needs to be known about HERV biology for their
potential pathology to be understood, and that enough is known for a search for corre-
37
lation to human disease to be called for. For example the correlations between HERVs
and conditions or between HERVs and genes. New technology or another form of a
paradigm shift would be required for the nature of HERV research to change. How-
ever, even correlation studies could be done better. True leaps in understanding of
HERVs will be through utilization of multiple avenues of analysis. Minimizing any
issues that could compromise the results while maximizing the strength of the pre-
dictions is what should next be done in this research field.
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